Single‐Molecule All‐In‐One (SMALL) Dendritic Dots for Precise Cancer Theranostics
Advanced Materials · 2026-03 · 38 (18)
DOI: 10.1002/adma.202508639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 02.03.2026. Verfasst von Yuji Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical and Biological Engineering, Key Laboratory of Biomass Chemical Engineering of Ministry of Education and Zhejiang Key Laboratory o…. Hauptthemen laut MEDLINE: Dendrimers, Theranostic Nanomedicine, Drug Carriers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Multifunctional nanoparticles with diverse cargos have been extensively developed for efficient cancer theranostics. However, the requirement of additional components would result in stochastic functionalization, interfering with the precise structure and desired characteristics. Thus, it is requisite and challenging to develop multifunctional nanoparticles with a single component. Herein, we report a universal, modular and scalable design approach for constructing a type of single‐molecule all‐in‐one (SMALL) dendritic dots (DDs) with well‐defined functional architectures for customizable theranostics. These SMALL DDs are prepared through dendrimer‐based divergent synthesis by orthogonal protection, selective deprotection, and precise conjugation. To demonstrate the feasibility of the strategy, we synthesized a type of perylenediimide (PDI)‐cored and camptothecin‐loaded polylysine dendrimer‐based SMALL DDs. These DDs possess precise structure, tunable drug loading, well‐defined particle size, and bright and stable fluorescence. The SMALL DDs exhibit long blood circulation, superior tumor accumulation, and tumor‐associated enzyme‐responsive drug release and generate potent antitumor activity in mice bearing hepatocellular carcinoma. The SMALL DDs integrate imaging probes, drug molecules, and targeting and responsive ligands into a single molecule, which provides a strategy to solve the dilemma of multifunctionality and structural precision and is promising for cancer theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical and Biological Engineering, Key Laboratory of Biomass Chemical Engineering of Ministry of Education and Zhejiang Key Laboratory of Smart Biomaterials, Zhejiang University, Hangzhou, P. R. China.
- Department of Neurosurgery, West China Hospital Sichuan University, Chengdu, P. R. China.
ORCID-Profile: Zhuxian Zhou
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Sun, Y., Zheng, Y., Wang, Z., Gao, K., Zhu, Y., Zhao, Z., Piao, Y., Dong, C., Shen, Y., & Zhou, Z. (2026). Single‐Molecule All‐In‐One (SMALL) Dendritic Dots for Precise Cancer Theranostics. Advanced Materials, 38(18). https://doi.org/10.1002/adma.202508639
Vancouver
Sun Y, Zheng Y, Wang Z, Gao K, Zhu Y, Zhao Z, et al. Single‐Molecule All‐In‐One (SMALL) Dendritic Dots for Precise Cancer Theranostics. Advanced Materials. 2026;38(18). doi:10.1002/adma.202508639
BibTeX
@article{Sun2026,
author = {Sun, Yuji and Zheng, Yihuan and Wang, Zhehao and Gao, Kai and Zhu, Yincong and Zhao, Zhihao and Piao, Ying and Dong, Chengyuan and Shen, Youqing and Zhou, Zhuxian},
title = {Single‐Molecule All‐In‐One (SMALL) Dendritic Dots for Precise Cancer Theranostics},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {18},
doi = {10.1002/adma.202508639}
}
EUVIMED